The DOI matches its Crossref record; 80 of the 80 references it cites were found in a registry or an index.
Praziquantel: mechanisms of action, resistance and new derivatives for schistosomiasis
Abstract
PURPOSE OF REVIEW: Praziquantel (PZQ) is the only drug being used to treat human schistosomiasis on a large scale. This review focuses on current knowledge about the mechanisms of action of PZQ, prospects for PZQ resistance, possible future alternative drugs and on exhortations that control of schistosomiasis and other so-called neglected tropical diseases becomes more integrated. RECENT FINDINGS: Schistosome calcium ion (Ca2+) channels are the only moiety so far identified as the molecular target of PZQ, but the evidence remains indirect. In the presence of cytochalasin D worms survive high concentrations of PZQ and experiments with cytochalasin D also indicated that PZQ induced worm death and Ca2+ influx are not correlated. Despite PZQ being widely used, there is no clinically relevant evidence for resistance to date, but worryingly low-cure rates have been recorded in some studies in Africa. Artemisinins and the related 1,2,4-trioxolanes are new promising antischistosomal compounds, as are inhibitors of a schistosome-specific bifunctional enzyme, thioredoxin-glutathione reductase. SUMMARY: Use of PZQ will increase in the foreseeable future, whether given alone or coadministered with other anthelminthics in integrated control programmes. PZQ resistance remains a threat and its prevention requires adequate monitoring of current mass drug administration programmes and development of new schistosomicides.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Steinmann, P., Keiser, J., Bos, R., Tanner, M., & Utzinger, J. (2006) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(06)70521-7 · Cited by 2,156
Self-citationGryseels, B., Polman, K., Clerinx, J., & Kestens, L. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69440-3 · Cited by 2,084
Control of Neglected Tropical Diseases
Hotez, P. J., Molyneux, D. H., Fenwick, A., Kumaresan, J., Sachs, S. E., Sachs, J. D., & Savioli, L. (2007) · New England Journal of Medicine · doi:10.1056/nejmra064142 · Cited by 1,585
Helminth infections: the great neglected tropical diseases
Hotez, P. J., Brindley, P. J., Bethony, J. M., King, C. H., Pearce, E. J., & Jacobson, J. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34261 · Cited by 1,568
Qinghaosu (Artemisinin): The Price of Success
White, N. J. (2008) · Science · doi:10.1126/science.1155165 · Cited by 954
Quantification of clinical morbidity associated with schistosome infection in sub-Saharan Africa
van der Werf, M. J., de Vlas, S. J., Brooker, S., Looman, C. W. N., Nagelkerke, N. J. D., Habbema, J. D. F., & Engels, D. (2003) · Acta Tropica · doi:10.1016/s0001-706x(03)00029-9 · Cited by 951
King, C. H., Dickman, K., & Tisch, D. J. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66457-4 · Cited by 899
Identification of an antimalarial synthetic trioxolane drug development candidate
Vennerstrom, J. L., Arbe-Barnes, S., Brun, R., Charman, S. A., Chiu, F. C. K., Chollet, J., Dong, Y., Dorn, A., Hunziker, D., Matile, H., et al. (2004) · Nature · doi:10.1038/nature02779 · Cited by 622
The unacknowledged impact of chronic schistosomiasis
King, C. H., & Dangerfield-Cha, M. (2008) · Chronic Illness · doi:10.1177/1742395307084407 · Cited by 530
Innovative lead discovery strategies for tropical diseases
Nwaka, S., & Hudson, A. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2144 · Cited by 521
Mattiucci, S., & Nascetti, G. (2008) · Advances in Parasitology · doi:10.1016/s0065-308x(08)00202-9 · Cited by 505
Fallon, P. G., & Doenhoff, M. J. (1994) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1994.51.83 · Cited by 483
Self-citationAlbendazole, mebendazole and praziquantel. Review of non-clinical toxicity and pharmacokinetics
Dayan, A. D. (2003) · Acta Tropica · doi:10.1016/s0001-706x(03)00031-7 · Cited by 371
Kuntz, A. N., Davioud-Charvet, E., Sayed, A. A., Califf, L. L., Dessolin, J., Arnér, E. S. J., & Williams, D. L. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040206 · Cited by 365
Pica‐Mattoccia, L., & Cioli, D. (2004) · International Journal for Parasitology · doi:10.1016/j.ijpara.2003.12.003 · Cited by 364
Self-citationSchistosoma mansoni: Chemotherapy of infections of different ages
Sabah, A. A., Fletcher, C., Webbe, G., & Doenhoff, M. J. (1986) · Experimental Parasitology · doi:10.1016/0014-4894(86)90184-0 · Cited by 360
Self-citationCioli, D., & Pica-Mattoccia, L. (2003) · Parasitology Research · doi:10.1007/s00436-002-0751-z · Cited by 343
Self-citationSchistosomiasis and soil-transmitted helminthiasis: common drugs for treatment and control
Utzinger, J., & Keiser, J. (2004) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.5.2.263 · Cited by 329
Self-citationIsmail, M., Metwally, A., Farghaly, A., Bruce, J., Tao, L.-F., & Bennett, J. L. (1996) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1996.55.214 · Cited by 315
Efficacy and Side Effects of Praziquantel in an Epidemic Focus of Schistosoma mansoni
Stelma, F. F., Talla, I., Sow, S., Kongs, A., Niang, M., Polman, K., Deelder, A. M., & Gryseels, B. (1995) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1995.53.167 · Cited by 310
Drugs for the control of parasitic diseases: current status and development in schistosomiasis
Fenwick, A., Savioli, L., Engels, D., Robert Bergquist, N., & Todd, M. H. (2003) · Trends in Parasitology · doi:10.1016/j.pt.2003.09.005 · Cited by 299
Chemotherapy of schistosomiasis: present and future
Caffrey, C. R. (2007) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2007.05.031 · Cited by 277
Identification of oxadiazoles as new drug leads for the control of schistosomiasis
Sayed, A. A., Simeonov, A., Thomas, C. J., Inglese, J., Austin, C. P., & Williams, D. L. (2008) · Nature Medicine · doi:10.1038/nm1737 · Cited by 270
Schistosomiasis Mansoni: Novel Chemotherapy Using a Cysteine Protease Inhibitor
Abdulla, M.-H., Lim, K.-C., Sajid, M., McKerrow, J. H., & Caffrey, C. R. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040014 · Cited by 269
Antischistosomal drugs: Past, present … and future?
Cioli, D., Pica-Mattoccia, L., & Archer, S. (1995) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(95)00026-7 · Cited by 259
Self-citationSchistosomiasis: challenges for control, treatment and drug resistance
Fenwick, A., & Webster, J. P. (2006) · Current Opinion in Infectious Diseases · doi:10.1097/01.qco.0000247591.13671.6a · Cited by 254
Waterborne Infectious DiseasesCould They Be Consigned to History?
Fenwick, A. (2006) · Science · doi:10.1126/science.1127184 · Cited by 252
Pax, R., Bennett, J. L., & Fetterer, R. (1978) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/bf00507974 · Cited by 234
Artemisinins for schistosomiasis and beyond.
Utzinger, J., Xiao, S.-H., Tanner, M., & Keiser, J. (2007) · PubMed · Cited by 232
Self-citationOral artemether for prevention of Schistosoma mansoni infection: randomised controlled trial
Utzinger, J., N'Goran, E. K., N'Dri, A., Lengeler, C., Shuhua, X., & Tanner, M. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02114-0 · Cited by 218
Self-citationA blueprint for success: integration of neglected tropical disease control programmes
Lammie, P. J., Fenwick, A., & Utzinger, J. (2006) · Trends in Parasitology · doi:10.1016/j.pt.2006.05.009 · Cited by 204
Self-citationDoenhoff, M. J., & Pica-Mattoccia, L. (2006) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.4.2.199 · Cited by 203
Self-citationA Breakthrough in R&D for Neglected Diseases: New Ways to Get the Drugs We Need
Moran, M. (2005) · PLoS Medicine · doi:10.1371/journal.pmed.0020302 · Cited by 198
Interpreting low praziquantel cure rates of Schistosoma mansoni infections in Senegal
Danso-Appiah, A., & De Vlas, S. J. (2002) · Trends in Parasitology · doi:10.1016/s1471-4922(01)02209-7 · Cited by 197
Brindley, P. J., & Sher, A. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.139.1.215 · Cited by 195
In Vitro and In Vivo Activities of Synthetic Trioxolanes against Major Human Schistosome Species
Xiao, S.-H., Keiser, J., Chollet, J., Utzinger, J., Dong, Y., Endriss, Y., Vennerstrom, J. L., & Tanner, M. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01537-06 · Cited by 184
Self-citationFriedman, J. F., Mital, P., Kanzaria, H. K., Olds, G. R., & Kurtis, J. D. (2007) · Trends in Parasitology · doi:10.1016/j.pt.2007.02.006 · Cited by 180
Becker, B., Mehlhorn, H., Andrews, P., Thomas, H., & Eckert, J. (1980) · Zeitschrift f�r Parasitenkunde Parasitology Research · doi:10.1007/bf00927527 · Cited by 177
Implementation of Human Schistosomiasis Control: Challenges and Prospects
Fenwick, A., Rollinson, D., & Southgate, V. (2006) · Advances in Parasitology · doi:10.1016/s0065-308x(05)61013-5 · Cited by 168
Projected benefits from integrating NTD programs in sub-Saharan Africa
Brady, M. A., Hooper, P. J., & Ottesen, E. A. (2006) · Trends in Parasitology · doi:10.1016/j.pt.2006.05.007 · Cited by 162
Southgate, V. R. (1997) · Journal of Helminthology · doi:10.1017/s0022149x00015790 · Cited by 159
King, C. H., & Bertino, A.-M. (2008) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0000209 · Cited by 157
Artemisinins and synthetic trioxolanes in the treatment of helminth infections
Keiser, J., & Utzinger, J. (2007) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e3282f19ec4 · Cited by 152
Self-citationALONSO, D., Muñóz, J., Gascón, J., Valls, M. E., & Corachan, M. (2006) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2006.74.342 · Cited by 140
Evidence for an immune-dependent action of praziquantel on Schistosoma mansoni in mice
Doenhoff, M. J., Sabah, A. A. A., Fletcher, C., Webbe, G., & Bain, J. (1987) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/0035-9203(87)90360-9 · Cited by 140
Self-citationParker, M., Allen, T., & Hastings, J. (2007) · Journal of Biosocial Science · doi:10.1017/s0021932007002301 · Cited by 136
Xiao, S.-H. (2005) · Acta Tropica · doi:10.1016/j.actatropica.2005.07.010 · Cited by 134
Harnett, W., & Kusel, J. R. (1986) · Parasitology · doi:10.1017/s0031182000051568 · Cited by 130
Chen, M. (2005) · Acta Tropica · doi:10.1016/j.actatropica.2005.07.011 · Cited by 129
Current status of sensitivity to praziquantel in a focus of potential drug resistance in Egypt
Botros, S. S., Sayed, H. A. E., Amer, N. M., El-Ghannam, M., Bennett, J. L., & Day, T. A. (2005) · International Journal for Parasitology · doi:10.1016/j.ijpara.2005.02.005 · Cited by 128
Brooker, S., Kabatereine, N. B., Fleming, F. M., & Devlin, N. J. (2007) · Health Policy and Planning · doi:10.1093/heapol/czm041 · Cited by 127
Cioli, D., Botros, S. S., Wheatcroft-Francklow, K., Mbaye, A. I., Southgate, V. R., Tchuenté, L.-A. T., Pica‐Mattoccia, L., Troiani, A. R., el-Din, S. H. S., Sabra, A.-N. A., et al. (2004) · International Journal for Parasitology · doi:10.1016/j.ijpara.2004.05.001 · Cited by 126
Self-citationNew initiatives against Africa's worms
Fenwick, A. (2005) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/j.trstmh.2005.03.014 · Cited by 119
New policies for using anthelmintics in high risk groups
Allen, H., Crompton, D. W. T., de Silva, N., LoVerde, P. T., & Olds, G. R. (2002) · Trends in Parasitology · doi:10.1016/s1471-4922(02)02386-3 · Cited by 116
Schistosomiasis in African infants and preschool children: to treat or not to treat?
Stothard, J. R., & Gabrielli, A.-F. (2007) · Trends in Parasitology · doi:10.1016/j.pt.2007.01.005 · Cited by 115
Quantitative High-Throughput Screen Identifies Inhibitors of the Schistosoma mansoni Redox Cascade
Simeonov, A. M., Jadhav, A., Sayed, A. A., Wang, Y., Nelson, M. E., Thomas, C. J., Inglese, J., Williams, D. L., & Austin, C. P. (2008) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0000127 · Cited by 111
Schistosomiasis control: keep taking the tablets
Hagan, P., Appleton, C. C., Coles, G. C., Kusel, J. R., & Tchuem-Tchuenté, L. A. (2003) · Trends in Parasitology · doi:10.1016/j.pt.2003.11.010 · Cited by 105
Schistosomiasis—a century searching for chemotherapeutic drugs
Ribeiro‐dos‐Santos, G., Verjovski‐Almeida, S., & Leite, L. C. C. (2006) · Parasitology Research · doi:10.1007/s00436-006-0175-2 · Cited by 104
N’GORAN, E. K., Utzinger, J., GNAKA, H. N., YAPI, A., N’Guessan, N. A., Silué, K. D., Lengeler, C., Chollet, J., SHUHUA, X., & Tanner, M. (2003) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2003.68.24 · Cited by 104
Self-citationEfficacy of praziquantel against Schistosoma mansoni in northern Senegal
Picquet, M., Vercruysse, J., Shaw, D. J., Diop, M., & Ly, A. (1998) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/s0035-9203(98)90971-3 · Cited by 100
Recent progress in integrated neglected tropical disease control
Hotez, P. J., Raff, S., Fenwick, A., Richards, F., & Molyneux, D. H. (2007) · Trends in Parasitology · doi:10.1016/j.pt.2007.08.015 · Cited by 99
Raso, G., N'Goran, E. K., Toty, A., Luginbühl, A., Adjoua, C. A., Tian‐Bi, N. T., Bogoch, I. I., Vounatsou, P., Tanner, M., & Utzinger, J. (2003) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/s0035-9203(03)00003-8 · Cited by 99
Self-citationOlsen, A. (2007) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/j.trstmh.2007.03.006 · Cited by 96
Voltage-gated calcium channel subunits from platyhelminths: potential role in praziquantel action.
Jeziorski, M. C., & Greenberg, R. (2006) · International Journal of Parasitology · doi:10.1016/j.ijpara.2006.02.002 · Cited by 96
Assessment of the age-specific disability weight of chronic schistosomiasis japonica
Zhou, X.-N. (2007) · Bulletin of the World Health Organization · doi:10.2471/blt.06.033035 · Cited by 96
The anti-schistosomal drug praziquantel is an adenosine antagonist
Angelucci, F., Basso, A. B. G., Bellelli, A., Brunori, M., Pica‐Mattoccia, L., & Valle, C. (2007) · Parasitology · doi:10.1017/s0031182007002600 · Cited by 89
Finkelstein, J. L., Schleinitz, M. D., Carabin, H., & McGarvey, S. T. (2008) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0000158 · Cited by 84
Neglected tropical diseases in Uganda: the prospect and challenge of integrated control
Kolaczinski, J. H., Kabatereine, N. B., Onapa, A. W., Ndyomugyenyi, R., Kakembo, A. S. L., & Brooker, S. J. (2007) · Trends in Parasitology · doi:10.1016/j.pt.2007.08.007 · Cited by 82
Control of Neglected Tropical Diseases: Integrated Chemotherapy and Beyond
Utzinger, J., & de Savigny, D. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030112 · Cited by 78
Self-citationSchistosomicidal activity of the antimalarial drug, mefloquine, in Schistosoma mansoni-infected mice
Nassauw, L. V., Toovey, S., den bosch, J. V. O., Timmermans, J., & Vercruysse, J. (2008) · Travel Medicine and Infectious Disease · doi:10.1016/j.tmaid.2008.06.006 · Cited by 73
Towards control of schistosomiasis in sub-Saharan Africa
Southgate, V. R., Rollinson, D., Tchuenté, L. A. T., & Hagan, P. (2005) · Journal of Helminthology · doi:10.1079/joh2005307 · Cited by 72
Pica‐Mattoccia, L., Orsini, T., Basso, A., Festucci, A., Liberti, P., Guidi, A., Marcatto-Maggi, A.-L., Nobre-Santana, S., Troiani, A. R., Cioli, D., et al. (2008) · Experimental Parasitology · doi:10.1016/j.exppara.2008.03.012 · Cited by 70
Self-citationAdvances in the discovery and development of trematocidal drugs
Keiser, J., & Utzinger, J. (2007) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2.s1.s9 · Cited by 69
Self-citationWill new antischistosomal drugs finally emerge?
Cioli, D., Valle, C., Angelucci, F., & Miele, A. E. (2008) · Trends in Parasitology · doi:10.1016/j.pt.2008.05.006 · Cited by 68
Self-citationKohn, A. B., ROBERTS-MISTERLY, J. M., Anderson, P. A. V., Khan, N. Y. A. J. A., & Greenberg, R. M. (2003) · Parasitology · doi:10.1017/s003118200300386x · Cited by 60
Effect of praziquantel on the immature stages of Schistosoma haematobium
Botros, S. S., Pica‐Mattoccia, L., William, S., et al. (2005) · International Journal for Parasitology · doi:10.1016/j.ijpara.2005.05.002 · Cited by 55
Cytochalasin D abolishes the schistosomicidal activity of praziquantel
Pica‐Mattoccia, L., Valle, C., Basso, A., Troiani, A. R., Vigorosi, F., Liberti, P., Festucci, A., & Cioli, D. (2006) · Experimental Parasitology · doi:10.1016/j.exppara.2006.09.017 · Cited by 53
Self-citationKohn, A. B., ROBERTS-MISTERLY, J. M., Anderson, P. A. V., & Greenberg, R. M. (2003) · International Journal for Parasitology · doi:10.1016/s0020-7519(03)00209-1 · Cited by 33
A Global Fund to Fight Neglected Tropical Diseases: Is the G8 Hokkaido Toyako 2008 Summit Ready?
Hotez, P. J., Molyneux, D. H., Fenwick, A., Savioli, L., & Takeuchi, T. (2008) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0000220 · Cited by 32
Is actin the praziquantel receptor?
Troiani, A. R., Pica‐Mattoccia, L., Valle, C., Cioli, D., Mignogna, G., Ronketti, F., & Todd, M. H. (2007) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2007.05.004 · Cited by 17
Self-citation
Cited by
Colley, D. G., Bustinduy, A. L., Secor, W. E., & King, C. H. (2014) · The Lancet · doi:10.1016/s0140-6736(13)61949-2 · Cited by 2,444
McManus, D. P., Dunne, D. W., Sacko, M., Utzinger, J., Vennervald, B. J., & Zhou, X.-N. (2018) · Nature Reviews Disease Primers · doi:10.1038/s41572-018-0013-8 · Cited by 1,145
Self-citationKeiser, J., & Utzinger, J. (2009) · Clinical Microbiology Reviews · doi:10.1128/cmr.00012-09 · Cited by 629
Self-citationCringoli, G., Rinaldi, L., Maurelli, M. P., & Utzinger, J. (2010) · Nature Protocols · doi:10.1038/nprot.2009.235 · Cited by 510
Self-citationDiagnosis and management of schistosomiasis
Gray, D. J., Ross, A. G., Li, Y.-S., & McManus, D. P. (2011) · BMJ · doi:10.1136/bmj.d2651 · Cited by 427
Metadata
- Authors
- Doenhoff, M. J., Cioli, D., & Utzinger, J.
- Venue
- Current Opinion in Infectious Diseases
- Published
- 2008-12
- Volume
- 21
- Issue
- 6
- Pages
- 659-667
- ISSN
- 0951-7375 (ISSN-L)
- OpenAlex
- W2067454999
- Cited by
- 806
- References
- 80
- FWCI
- 25.25
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.